Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Pomegranate extract exhibits in vitro activity against Clostridium difficile.

Finegold SM, Summanen PH, Corbett K, Downes J, Henning SM, Li Z.

Nutrition. 2014 Oct;30(10):1210-2. doi: 10.1016/j.nut.2014.02.029. Epub 2014 Mar 14.

PMID:
24976424
2.

Antimicrobial Activity of Pomegranate and Green Tea Extract on Propionibacterium Acnes, Propionibacterium Granulosum, Staphylococcus Aureus and Staphylococcus Epidermidis.

Li Z, Summanen PH, Downes J, Corbett K, Komoriya T, Henning SM, Kim J, Finegold SM.

J Drugs Dermatol. 2015 Jun;14(6):574-8.

PMID:
26091382
3.

Antimicrobial activity of pomegranate (Punica granatum L.) fruit peels.

Al-Zoreky NS.

Int J Food Microbiol. 2009 Sep 15;134(3):244-8. doi: 10.1016/j.ijfoodmicro.2009.07.002. Epub 2009 Jul 12.

PMID:
19632734
4.

Effect of drying on the bioactive compounds, antioxidant, antibacterial and antityrosinase activities of pomegranate peel.

Mphahlele RR, Fawole OA, Makunga NP, Opara UL.

BMC Complement Altern Med. 2016 May 26;16:143. doi: 10.1186/s12906-016-1132-y.

5.

Antimicrobial susceptibilities of Clostridium difficile isolated in Japan.

Kunishima H, Chiba J, Saito M, Honda Y, Kaku M.

J Infect Chemother. 2013 Apr;19(2):360-2. doi: 10.1007/s10156-013-0553-5. Epub 2013 Jan 22.

PMID:
23338015
6.

Antimicrobial activity of LFF571 and three treatment agents against Clostridium difficile isolates collected for a pan-European survey in 2008: clinical and therapeutic implications.

Debast SB, Bauer MP, Sanders IM, Wilcox MH, Kuijper EJ; ECDIS Study Group.

J Antimicrob Chemother. 2013 Jun;68(6):1305-11. doi: 10.1093/jac/dkt013. Epub 2013 Feb 18.

PMID:
23420839
7.

Comparison of Clostridium difficile minimum inhibitory concentrations obtained using agar dilution vs broth microdilution methods.

Hastey CJ, Dale SE, Nary J, Citron D, Law JH, Roe-Carpenter DE, Chesnel L.

Anaerobe. 2017 Apr;44:73-77. doi: 10.1016/j.anaerobe.2017.02.006. Epub 2017 Feb 7.

PMID:
28188880
8.

Pomegranate extract inhibits Staphylococcus aureus growth and subsequent enterotoxin production.

Braga LC, Shupp JW, Cummings C, Jett M, Takahashi JA, Carmo LS, Chartone-Souza E, Nascimento AM.

J Ethnopharmacol. 2005 Jan 4;96(1-2):335-9.

PMID:
15588686
9.

Pomegranate fruit components modulate human thrombin.

Cuccioloni M, Mozzicafreddo M, Sparapani L, Spina M, Eleuteri AM, Fioretti E, Angeletti M.

Fitoterapia. 2009 Jul;80(5):301-5. doi: 10.1016/j.fitote.2009.03.009. Epub 2009 Apr 7.

PMID:
19358882
10.

Antibacterial activity of teicoplanin against Clostridium difficile.

Wongwanich S, Kusum M, Phan-Urai R.

Southeast Asian J Trop Med Public Health. 1996 Sep;27(3):606-9.

PMID:
9185278
11.

Investigation of the MICs of fidaxomicin and other antibiotics against Hungarian Clostridium difficile isolates.

Eitel Z, Terhes G, Sóki J, Nagy E, Urbán E.

Anaerobe. 2015 Feb;31:47-9. doi: 10.1016/j.anaerobe.2014.08.002. Epub 2014 Aug 17.

PMID:
25139122
12.
13.

The anti-biofilm potential of pomegranate (Punica granatum L.) extract against human bacterial and fungal pathogens.

Bakkiyaraj D, Nandhini JR, Malathy B, Pandian SK.

Biofouling. 2013 Sep;29(8):929-37. doi: 10.1080/08927014.2013.820825. Epub 2013 Aug 1.

PMID:
23906229
14.

Structure-Activity Relationships of Antimicrobial Gallic Acid Derivatives from Pomegranate and Acacia Fruit Extracts against Potato Bacterial Wilt Pathogen.

Farag MA, Al-Mahdy DA, Salah El Dine R, Fahmy S, Yassin A, Porzel A, Brandt W.

Chem Biodivers. 2015 Jun;12(6):955-62. doi: 10.1002/cbdv.201400194.

PMID:
26080741
15.

In vitro susceptibility of genotypically distinct and clonal Clostridium difficile strains to oritavancin.

O'Connor R, Baines SD, Freeman J, Wilcox MH.

J Antimicrob Chemother. 2008 Oct;62(4):762-5. doi: 10.1093/jac/dkn276. Epub 2008 Jul 7.

PMID:
18606787
16.

Antibacterial activity of Aristolochia paucinervis Pomel.

Gadhi CA, Weber M, Mory F, Benharref A, Lion C, Jana M, Lozniewski A.

J Ethnopharmacol. 1999 Oct;67(1):87-92.

PMID:
10616964
17.

In vitro activity of OPT-80 tested against clinical isolates of toxin-producing Clostridium difficile.

Karlowsky JA, Laing NM, Zhanel GG.

Antimicrob Agents Chemother. 2008 Nov;52(11):4163-5. doi: 10.1128/AAC.00476-08. Epub 2008 Aug 25.

18.

Antimicrobial susceptibilities and serogroups of clinical strains of Clostridium difficile isolated in France in 1991 and 1997.

Barbut F, Decré D, Burghoffer B, Lesage D, Delisle F, Lalande V, Delmée M, Avesani V, Sano N, Coudert C, Petit JC.

Antimicrob Agents Chemother. 1999 Nov;43(11):2607-11.

19.

Antibacterial effect of Manuka honey on Clostridium difficile.

Hammond EN, Donkor ES.

BMC Res Notes. 2013 May 7;6:188. doi: 10.1186/1756-0500-6-188.

20.

Phenolic compounds and biological activity of Kitaibelia vitifolia.

Mašković P, Solujić S, Mihailović V, Mladenović M, Cvijović M, Mladenović J, Aćamović-Đoković G, Kurćubić V.

J Med Food. 2011 Dec;14(12):1617-23. doi: 10.1089/jmf.2011.0013. Epub 2011 Aug 30.

PMID:
21877950

Supplemental Content

Support Center